These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24732011)

  • 41. Filovirus emergence and vaccine development: a perspective for health care practitioners in travel medicine.
    Sarwar UN; Sitar S; Ledgerwood JE
    Travel Med Infect Dis; 2011 May; 9(3):126-34. PubMed ID: 21208830
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correlates of immunity to filovirus infection.
    Bradfute SB; Bavari S
    Viruses; 2011 Jul; 3(7):982-1000. PubMed ID: 21994766
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Crystal structure of the Měnglà virus VP30 C-terminal domain.
    Dong S; Wen K; Chu H; Li H; Yu Q; Wang C; Qin X
    Biochem Biophys Res Commun; 2020 Apr; 525(2):392-397. PubMed ID: 32093889
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ferrets Infected with Bundibugyo Virus or Ebola Virus Recapitulate Important Aspects of Human Filovirus Disease.
    Kozak R; He S; Kroeker A; de La Vega MA; Audet J; Wong G; Urfano C; Antonation K; Embury-Hyatt C; Kobinger GP; Qiu X
    J Virol; 2016 Oct; 90(20):9209-23. PubMed ID: 27489269
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Filovirus infection: pathogenesis and host specificity].
    Takada A
    Tanpakushitsu Kakusan Koso; 2007 Aug; 52(10 Suppl):1242-7. PubMed ID: 17824247
    [No Abstract]   [Full Text] [Related]  

  • 46. Outbreaks of filovirus hemorrhagic fever: time to refocus on the patient.
    Bausch DG; Feldmann H; Geisbert TW; Bray M; Sprecher AG; Boumandouki P; Rollin PE; Roth C;
    J Infect Dis; 2007 Nov; 196 Suppl 2():S136-41. PubMed ID: 17940941
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Single-Vector, Single-Injection Trivalent Filovirus Vaccine: Proof of Concept Study in Outbred Guinea Pigs.
    Mire CE; Geisbert JB; Versteeg KM; Mamaeva N; Agans KN; Geisbert TW; Connor JH
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S384-8. PubMed ID: 25957964
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Challenges, progress, and opportunities: proceedings of the filovirus medical countermeasures workshop.
    Hirschberg R; Ward LA; Kilgore N; Kurnat R; Schiltz H; Albrecht MT; Christopher GW; Nuzum E
    Viruses; 2014 Jul; 6(7):2673-97. PubMed ID: 25010768
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Broad and Temperature Independent Replication Potential of Filoviruses on Cells Derived From Old and New World Bat Species.
    Miller MR; McMinn RJ; Misra V; Schountz T; Müller MA; Kurth A; Munster VJ
    J Infect Dis; 2016 Oct; 214(suppl 3):S297-S302. PubMed ID: 27354372
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Marburg and Ebola hemorrhagic fevers--pathogens, epidemiology and therapy].
    Stock I
    Med Monatsschr Pharm; 2014 Sep; 37(9):324-30; quiz 331-2. PubMed ID: 25282746
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapeutics for filovirus infection: traditional approaches and progress towards in silico drug design.
    Shurtleff AC; Nguyen TL; Kingery DA; Bavari S
    Expert Opin Drug Discov; 2012 Oct; 7(10):935-54. PubMed ID: 22873527
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Innate immunity evasion mechanisms of filoviruses].
    Martin B; Decroly É
    Med Sci (Paris); 2018; 34(8-9):671-677. PubMed ID: 30230452
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Discovery and evolution of aloperine derivatives as novel anti-filovirus agents through targeting entry stage.
    Zhang X; Liu Q; Zhang N; Li QQ; Liu ZD; Li YH; Gao LM; Wang YC; Deng HB; Song DQ
    Eur J Med Chem; 2018 Apr; 149():45-55. PubMed ID: 29494844
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An update on the progress of galidesivir (BCX4430), a broad-spectrum antiviral.
    Julander JG; Demarest JF; Taylor R; Gowen BB; Walling DM; Mathis A; Babu YS
    Antiviral Res; 2021 Nov; 195():105180. PubMed ID: 34551346
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Will There Be a Cure for Ebola?
    Cardile AP; Warren TK; Martins KA; Reisler RB; Bavari S
    Annu Rev Pharmacol Toxicol; 2017 Jan; 57():329-348. PubMed ID: 27959624
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Small Animal Models for Studying Filovirus Pathogenesis.
    Yamaoka S; Banadyga L; Bray M; Ebihara H
    Curr Top Microbiol Immunol; 2017; 411():195-227. PubMed ID: 28653189
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Potential vaccines and post-exposure treatments for filovirus infections.
    Friedrich BM; Trefry JC; Biggins JE; Hensley LE; Honko AN; Smith DR; Olinger GG
    Viruses; 2012 Sep; 4(9):1619-50. PubMed ID: 23170176
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Current perspectives on the phylogeny of Filoviridae.
    Barrette RW; Xu L; Rowland JM; McIntosh MT
    Infect Genet Evol; 2011 Oct; 11(7):1514-9. PubMed ID: 21742058
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Electron tomography reveals the steps in filovirus budding.
    Welsch S; Kolesnikova L; Krähling V; Riches JD; Becker S; Briggs JA
    PLoS Pathog; 2010 Apr; 6(4):e1000875. PubMed ID: 20442788
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Screening and Reverse-Engineering of Estrogen Receptor Ligands as Potent Pan-Filovirus Inhibitors.
    Cooper L; Schafer A; Li Y; Cheng H; Medegan Fagla B; Shen Z; Nowar R; Dye K; Anantpadma M; Davey RA; Thatcher GRJ; Rong L; Xiong R
    J Med Chem; 2020 Oct; 63(19):11085-11099. PubMed ID: 32886512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.